These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18440222)

  • 1. Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity.
    Tentori L; Muzi A; Dorio AS; Bultrini S; Mazzon E; Lacal PM; Shah GM; Zhang J; Navarra P; Nocentini G; Cuzzocrea S; Graziani G
    Eur J Cancer; 2008 Jun; 44(9):1302-14. PubMed ID: 18440222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent.
    Tentori L; Muzi A; Dorio AS; Scarsella M; Leonetti C; Shah GM; Xu W; Camaioni E; Gold B; Pellicciari R; Dantzer F; Zhang J; Graziani G
    Curr Cancer Drug Targets; 2010 Jun; 10(4):368-83. PubMed ID: 20464779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.
    Tentori L; Lacal PM; Muzi A; Dorio AS; Leonetti C; Scarsella M; Ruffini F; Xu W; Min W; Stoppacciaro A; Colarossi C; Wang ZQ; Zhang J; Graziani G
    Eur J Cancer; 2007 Sep; 43(14):2124-33. PubMed ID: 17714938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor.
    Tentori L; Portarena I; Barbarino M; Balduzzi A; Levati L; Vergati M; Biroccio A; Gold B; Lombardi ML; Graziani G
    Mol Pharmacol; 2003 Jan; 63(1):192-202. PubMed ID: 12488552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP inhibitors for cancer therapy.
    Curtin NJ
    Expert Rev Mol Med; 2005 Mar; 7(4):1-20. PubMed ID: 15836799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
    Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
    Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
    Parsons JL; Dianova II; Allinson SL; Dianov GL
    FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death.
    Kauppinen TM; Swanson RA
    J Immunol; 2005 Feb; 174(4):2288-96. PubMed ID: 15699164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerase-1 modulation of in vivo response of brain hypoxia-inducible factor-1 to hypoxia/reoxygenation is mediated by nitric oxide and factor inhibiting HIF.
    Martínez-Romero R; Cañuelo A; Martínez-Lara E; Javier Oliver F; Cárdenas S; Siles E
    J Neurochem; 2009 Oct; 111(1):150-9. PubMed ID: 19656264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Poly(ADP-ribosa)polymerase--the relationships with life span and carcinogenesis].
    Piskunova TS; Iurova MN; Zabezhinskiĭ MA; Anisimov VN
    Adv Gerontol; 2007; 20(2):82-90. PubMed ID: 18306694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of poly(ADP-ribose) polymerase-1 reduces host cell reactivation of a UV-damaged adenovirus-encoded reporter gene in human dermal fibroblasts.
    Ghodgaonkar MM; Zacal N; Kassam S; Rainbow AJ; Shah GM
    DNA Repair (Amst); 2008 Apr; 7(4):617-32. PubMed ID: 18289944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury.
    Mota RA; Hernández-Espinosa D; Galbis-Martinez L; Ordoñez A; Miñano A; Parrilla P; Vicente V; Corral J; Yélamos J
    Crit Care Med; 2008 Feb; 36(2):526-34. PubMed ID: 18091544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.
    Staibano S; Pepe S; Lo Muzio L; Somma P; Mascolo M; Argenziano G; Scalvenzi M; Salvatore G; Fabbrocini G; Molea G; Bianco AR; Carlomagno C; De Rosa G
    Hum Pathol; 2005 Jul; 36(7):724-31. PubMed ID: 16084940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.
    Cover C; Fickert P; Knight TR; Fuchsbichler A; Farhood A; Trauner M; Jaeschke H
    Toxicol Sci; 2005 Mar; 84(1):201-8. PubMed ID: 15601672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of adhesion molecular proteins in the cochlear lateral wall of normal and PARP-1 mutant mice.
    Shi X; Nuttall AL
    Hear Res; 2007 Feb; 224(1-2):1-14. PubMed ID: 17184942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploinsufficiency of poly(ADP-ribose) polymerase-1-mediated poly(ADP-ribosyl)ation for centrosome duplication.
    Kanai M; Tong WM; Wang ZQ; Miwa M
    Biochem Biophys Res Commun; 2007 Aug; 359(3):426-30. PubMed ID: 17553458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major contribution of the multidrug transporter P-glycoprotein to reduced susceptibility of poly(ADP-ribose) polymerase-1 knock-out cells to doxorubicin action.
    Wesierska-Gadek J
    J Cell Biochem; 2005 Aug; 95(5):1012-28. PubMed ID: 15861398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1.
    Plummer ER; Middleton MR; Jones C; Olsen A; Hickson I; McHugh P; Margison GP; McGown G; Thorncroft M; Watson AJ; Boddy AV; Calvert AH; Harris AL; Newell DR; Curtin NJ
    Clin Cancer Res; 2005 May; 11(9):3402-9. PubMed ID: 15867241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.
    Karpel-Massler G; Pareja F; Aimé P; Shu C; Chau L; Westhoff MA; Halatsch ME; Crary JF; Canoll P; Siegelin MD
    PLoS One; 2014; 9(12):e114583. PubMed ID: 25531448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.